628 related articles for article (PubMed ID: 15591115)
1. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.
Glennie S; Soeiro I; Dyson PJ; Lam EW; Dazzi F
Blood; 2005 Apr; 105(7):2821-7. PubMed ID: 15591115
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.
Krampera M; Glennie S; Dyson J; Scott D; Laylor R; Simpson E; Dazzi F
Blood; 2003 May; 101(9):3722-9. PubMed ID: 12506037
[TBL] [Abstract][Full Text] [Related]
3. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells.
Gerhard M; Schmees C; Voland P; Endres N; Sander M; Reindl W; Rad R; Oelsner M; Decker T; Mempel M; Hengst L; Prinz C
Gastroenterology; 2005 May; 128(5):1327-39. PubMed ID: 15887115
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory properties of colonic mesenchymal stem cells.
Hu J; Zhang X; Zhou L; Zhang Y
Immunol Lett; 2013; 156(1-2):23-9. PubMed ID: 24060593
[TBL] [Abstract][Full Text] [Related]
5. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
[TBL] [Abstract][Full Text] [Related]
6. Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro.
Nazarov C; Lo Surdo J; Bauer SR; Wei CH
Stem Cell Res Ther; 2013 Oct; 4(5):128. PubMed ID: 24406271
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.
Rasmusson I; Uhlin M; Le Blanc K; Levitsky V
J Leukoc Biol; 2007 Oct; 82(4):887-93. PubMed ID: 17609339
[TBL] [Abstract][Full Text] [Related]
8. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
[TBL] [Abstract][Full Text] [Related]
9. Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4+ T cells.
Duthoit CT; Nguyen P; Geiger TL
J Immunol; 2004 Feb; 172(4):2238-46. PubMed ID: 14764692
[TBL] [Abstract][Full Text] [Related]
10. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
11. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
[TBL] [Abstract][Full Text] [Related]
12. [Effects of MSC on cell cycle, phenotype and cytokine secretion of T cells activated by PHA].
Luan XY; Zhang GB; Hu YM; Yu GH; Wang MY; Duan QY; Duan X; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):402-5. PubMed ID: 17488597
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: p27Kip1 deficiency reduces the requirement for CD28-mediated costimulation in naive CD8+ but not CD4+ T lymphocytes.
Wolfraim LA; Letterio JJ
J Immunol; 2005 Mar; 174(5):2481-4. PubMed ID: 15728451
[TBL] [Abstract][Full Text] [Related]
16. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
18. T cell effector function and anergy avoidance are quantitatively linked to cell division.
Wells AD; Walsh MC; Sankaran D; Turka LA
J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
[TBL] [Abstract][Full Text] [Related]
19. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
[TBL] [Abstract][Full Text] [Related]
20. IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice.
Gesbert F; Moreau JL; Thèze J
Int Immunol; 2005 Aug; 17(8):1093-102. PubMed ID: 16037071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]